Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes - Publication - Bridge of Knowledge

Your account

login

Search

Pharmacokinetics and Antibody Responses to the CD3 Antibody Otelixizumab Used in the Treatment of Type 1 Diabetes

Abstract

Citations

  • 3 6

    CrossRef

  • 0

    Web of Science

  • 3 9

    Scopus

Authors (13)

  • Photo of Geoff Hale

    Geoff Hale

  • Photo of Peppy Rebello

    Peppy Rebello

  • Photo of Ibrahim Al

    Ibrahim Al

  • Photo of Emma Bolam

    Emma Bolam

  • Photo of Pawel Wiczling

    Pawel Wiczling

  • Photo of William Jusko

    William Jusko

  • Photo of Evy Vandemeulebroucke

    Evy Vandemeulebroucke

  • Photo of Bart Keymeulen

    Bart Keymeulen

  • Photo of Chantal Mathieu

    Chantal Mathieu

  • Photo of Annette-G Ziegler

    Annette-G Ziegler

  • Photo of Lucienne Chatenoud

    Lucienne Chatenoud

  • Photo of Herman Waldmann

    Herman Waldmann

  • Photo of Paweł Wiczling

    Paweł Wiczling

Cite as

Full text

full text is not available in portal

Details

Category:
Magazine publication
Type:
Magazine publication
Published in:
JOURNAL OF CLINICAL PHARMACOLOGY no. 50, edition 11, pages 1238 - 1248,
ISSN: 0091-2700
ISSN:
00912700
Publication year:
2010
DOI:
Digital Object Identifier (open in new tab) 10.1177/0091270009356299
Verified by:
No verification

seen 38 times

Meta Tags